110020 Stock Chart & Stats
₩2025.00
₩32.00(1.61%)
―
--
Day’s Range― - ―
52-Week Range₩1,482.00 - ₩3,485.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)9.86K
Market Cap
₩18.05B
Enterprise Value₩9.66K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-24.14
Shares Outstanding9,058,762
10 Day Avg. Volume6,116
30 Day Avg. Volume9,856
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
110020 FAQ
What was JEONJINBIO Co., Ltd.’s price range in the past 12 months?
JEONJINBIO Co., Ltd. lowest stock price was ₩1482.00 and its highest was ₩3485.00 in the past 12 months.
What is JEONJINBIO Co., Ltd.’s market cap?
JEONJINBIO Co., Ltd.’s market cap is ₩18.05B.
When is JEONJINBIO Co., Ltd.’s upcoming earnings report date?
JEONJINBIO Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 64 days.
How were JEONJINBIO Co., Ltd.’s earnings last quarter?
JEONJINBIO Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -₩24.14 earnings per share for the quarter.
Is JEONJINBIO Co., Ltd. overvalued?
According to Wall Street analysts JEONJINBIO Co., Ltd.’s price is currently Undervalued.
Does JEONJINBIO Co., Ltd. pay dividends?
JEONJINBIO Co., Ltd. does not currently pay dividends.
What is JEONJINBIO Co., Ltd.’s EPS estimate?
JEONJINBIO Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JEONJINBIO Co., Ltd. have?
JEONJINBIO Co., Ltd. has 9,058,762 shares outstanding.
What happened to JEONJINBIO Co., Ltd.’s price movement after its last earnings report?
JEONJINBIO Co., Ltd. reported an EPS of -₩24.14 in its last earnings report. Following the earnings report the stock price went up 11.502%.
Which hedge fund is a major shareholder of JEONJINBIO Co., Ltd.?
Currently, no hedge funds are holding shares in KR:110020
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
HUMASIS Co., Ltd.
―
SD Biotechnologies Co., Ltd.
―
Xcell Therapeutics, Inc.
―
From Bio Co., Ltd.
―
BISTOS Co., Ltd.
―